Skip to main content
. 2013 Mar 20;27(3):445–450. doi: 10.1111/jvim.12058

Table 1.

Primers used in directed reverse transcription and PCR reactions

Target Site on Genome Direction Primer Name Oligonucleotide Sequence Estimated Product Sizea
Replicase polyprotein (amino‐proximal region of nsp3) Forward FCoV nsp3 A F1 5′‐ATCCATATGGTTCTGGCATGG‐3′ 730–970 bp
Reverse FCoV nsp3 A R2 5′‐TTTAGCYGTACTATAATCATTGAGCA‐3′
Replicase polyprotein (carboxyl‐proximal region of nsp12) Forward FCoV nsp12 B F1 5′‐CCCACAATGACTCAAATGAA‐3′ 800 bp
Reverse FCoV nsp12 B R1 5′‐TCTGGTTCYACCCAACACTT‐3′
Amino‐proximal region of the surface glycoproteinb Forward FCoV S1 F1 5′‐TCTGTKGCCATCAAAATCAC‐3′ 1900 bp
Reverse FCoV S1 R1 5′‐CATTAACATCHACCATTACATCTG‐3′
Forward FCoV S1 FB 5′‐GGAAGAGAATCAGCCTCACG‐3′ Sequencing primers
Forward FCoV S1 FC 5′‐TTGCGCTGGTTATGCTAAGA‐3′
Reverse FCoV S1 RB 5′‐CACGACCCTGTACCAATGTG‐3′
Reverse FCoV S1 RC 5′‐CACCTGTCCCACAGTATGGT‐3′
Membrane glycoproteinb Forward FCoV M F1 5′‐GCGGTTMTAAACGAAATTGA‐3′ 1040 bp
Reverse FCoV M R1 5′‐TGAGTAATCACCRGCTTTAGATTT‐3′
a

Based on available feline FCoV genome sequences.

b

Sequence variability in the 5′ region of the surface and membrane glycoproteins necessitated the placement of the forward primer in the preceding highly conserved regions of the nsp16 and small envelope protein genes respectively.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.